Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LNR and KRAS in Colon Cancer Risk Stratification
NCT04342676Phase 3Completed
- Sponsor
- Mansoura University
- Start
- Mar 2017
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
Phase 3, single-arm trial, sponsored by Mansoura University. Primary endpoint: Correlation of Lymph Node Ratio and KRAS mutation with clinicopathological parameters at 2 years. Started Mar 2017; status: completed.
Beyond the preview
Go deeper on NCT04342676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04342676.